Standard BioTools Inc. Litigation Settlement Loss
Standard BioTools Inc. (LAB) reported Litigation Settlement Loss of $600.00 thousand for the 12-month period ending 2024-12-31, per its 10-Q filed 2025-11-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementLoss · last filed 2025-11-04
- Standard BioTools Inc. litigation settlement loss for the quarter ending 2024-12-31 was $0.00.
- Standard BioTools Inc. litigation settlement loss for the quarter ending 2024-09-30 was $0.00.
| Period end | Litigation Settlement Loss 3 month | Litigation Settlement Loss 6 month | Litigation Settlement Loss 9 month | Litigation Settlement Loss 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $600.00K 10-Q · filed 2025-11-04 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $600.00K 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | $600.00K 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |